RT Journal Article
SR Electronic
T1 2104 Lupus autoantibodies associated with cell cycle gene expression in peripheral blood of SLE patients
JF Lupus Science & Medicine
JO Lupus Sci Med
FD Lupus Foundation of America
SP A110
OP A111
DO 10.1136/lupus-2022-lupus21century.112
VO 9
IS Suppl 3
A1 Olferiev, Mikhail
A1 Greenman, Dina
A1 Zhang-Sun, Jeffrey
A1 Fernandez, David
A1 Kirou, Kyriakos A
A1 Crow, Mary K
YR 2022
UL http://lupus.bmj.com/content/9/Suppl_3/A110.abstract
AB Background Gene-expression studies of SLE peripheral blood indicate the expression of relevant categories of functionally related transcripts. The most pronounced changes have been reported among interferon-inducible genes, genes specific to neutrophil granules and genes involved in cell cycle. Although autoantibodies are considered to be the main pathogenic mediators in SLE, there is little knowledge regarding how their titer is associated with peripheral blood gene expression. To gain insight into mechanisms of autoimmunity, we simultaneously investigated the presence of classical SLE autoantibodies (ANA, dsDNA, Sm/RNP, Ro, La) and gene expression in a cohort of 80 SLE patients followed from 1 to 14 visits over a period of 3(0- 12) years.Methods All blood samples were collected at HSS and processed within 1 hour using the same protocol. Gene expression was studied either by RNA-seq (62 samples) or DNA microarray (189 samples) and then merged into a single matrix using the MatchMixeR software. The obtained matrix was used to generate functionally annotated groups of co-expressed genes, also known as gene-modules, using the WGCNA algorithm. The comparison of autoantibody titer with gene expression was analyzed by linear mixed model, using either a per module or per gene approach. Several clustering techniques were used to aggregate common genes and investigate the association with clinical and laboratory parameters.Results All studied patients fulfilled ACR criteria for SLE and received standard care at HSS. We excluded samples obtained after treatment with biologics (rituximab, belimumab).Autoantibodies expressed above the normal range were detected in the following frequencies: 90% ANA, 85% dsDNA, 84% Histone, 54% Sm/RNP, 32% Sm, 65% Ro52(SSA), and 23% La(SSB) A significant negative correlation between the described autoantibodies and level of complement C3 was observed. Based on gene expression, the only significant association was obtained for genes involved in cell division. Among those, the strongest association was demonstrated with anti-dsDNA titer. Among cell cycle related genes, the most significant correlations (p < 10-5) were seen for TK1, AURKB, KIFC1, KIF15, FOXM1, GINS2, NGAPG, CDC45, CDCA5, CCNA1, CCNB1.Conclusions Autoantibodies directed against nucleic acid-containing immune complexes are a characteristic trait in SLE. The aberrant expression of TK1 has been previously shown in bone marrow of SLE patients. Cell-cycle related genes were identified earlier in microarray studies of SLE PBMC. However, association of those transcripts with autoantibodies has not been previously described. Abnormal expression of genes related to cell cycle might cause cell cycle arrest, a DNA damage response, senescence, and self-destruction. Those cellular events might in turn trigger overproduction of antinuclear antibodies.Lay Summary To gain insight into mechanisms of autoimmunity, we simultaneously investigated the presence of classical SLE autoantibodies (ANA, dsDNA, Sm/RNP, Ro, La) and gene expression in a cohort of 80 SLE patients followed longitudinally. We observed a significant association between antiantibodies titers and genes involved in cell division The aberrant expression of cell-cycle related genes might cause cell cycle arrest, DNA destruction, and enhanced antinuclear antibodies production in SLE.